Market Cap (In ILA)
7.45 Million
Revenue (In ILA)
-
Net Income (In ILA)
-14.19 Million
Avg. Volume
41.11 Thousand
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.018-159.0
- PE
- -1.13
- EPS
- -0.58
- Beta Value
- 0.855
- ISIN
- IL0010839301
- CUSIP
- -
- CIK
- -
- Shares
- 11421900.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Harel Hershtik
- Employee Count
- -
- Website
- https://www.nextgen-biomed.com
- Ipo Date
- 2002-08-12
- Details
- Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
More Stocks
-
EQGPFEQB Inc.
EQGPF
-
0RWMBitcoin Group SE
0RWM
-
1214
-
HAWAENGHawa Engineers Limited
HAWAENG
-
CENERCenergy Holdings SA
CENER
-
FTAIFTAI Aviation Ltd.
FTAI
-
UNISONUNISON METALS LTD
UNISON
-
TOBIITobii AB (publ)
TOBII